Physician profile
Jonathan Murdock
NPI 1467876649
$40,613.42
in general payments reported to CMS, 2019-2025
28 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,550 · 2020: $1,170 · 2021: $1,873 · 2022: $2,018 · 2023: $7,409 · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $26K · Food and Beverage: $6,282 · Travel and Lodging: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $26,416.67 |
| Food and Beverage | $6,281.96 |
| Travel and Lodging | $1,303.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $26,470.83 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Smart Port Ct |
| Endologix LLC | $3,790.79 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Abbott Laboratories | $2,230.98 | 2024-2025 | Perclose Proglide, Diamondback Peripheral, Esprit |
| W. L. Gore & Associates, INC. | $1,904.70 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore-Tex Vascular Graft |
| Silk Road Medical, INC. | $1,064.00 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $976.42 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $973.28 | 2019-2020 | |
| Imperative Care, INC | $668.00 | 2025 | Prodigy Catheter, Symphony Catheter |
| Medtronic, INC. | $563.55 | 2021-2025 | Venaseal, Heli-Fx Endoanchor System, Valiant Captivia |
| Philips North America LLC | $338.56 | 2022 | |
| Smith+Nephew, INC. | $299.26 | 2021-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Cook Medical LLC | $292.60 | 2023-2024 | Zenith |
| Polarityte, INC. | $188.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $187.90 | 2019-2022 | |
| Terumo Medical Corporation | $147.79 | 2023-2025 | Glidewire, Glidesheath Slender, Navicross |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $123.25 | 2019 | |
| Integra Lifesciences Corporation | $89.73 | 2020-2022 | |
| Bolton Medical INC | $46.70 | 2024 | Treo Abdominal Stent-Graft System |
| Convatec INC. | $38.82 | 2024 | |
| Cardiva Medical, INC. | $38.72 | 2019 | |
| Teleflex LLC | $34.69 | 2020-2025 | Manta |
| Cordis US Corp. | $33.82 | 2023-2024 | Saber, Mynx Control |
| Solventum Corporation | $28.72 | 2025 | Prevena |
| Boston Scientific Corporation | $24.04 | 2023 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $15.38 | 2024 | Venclose Maven Catheter |
| Inspiremd Ltd | $14.78 | 2025 | Cguard Prime Carotid Stent System |
| Cardiovascular Systems INC. | $14.35 | 2021 | |
| Kci USA, INC. | $13.17 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.